Rare diseases
Investigational molecules
Locations
175 Innovation Boulevard, 19805, United States
Prelude Therapeutics Inc. supports clinical research in advanced or metastatic solid tumors with a focus on SMARCA4 mutation-driven disease, including non-small cell lung cancer, esophageal cancer, and other refractory solid malignancies.
The sponsor’s oncology portfolio includes studies centered on molecularly defined tumors and treatment-resistant disease across multiple thoracic and gastrointestinal cancers.
Prelude Therapeutics Inc. runs clinical trials in conditions such as Neoplasm malignant, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
